|4Jan 23, 4:21 PM ET

VioQuest Pharmaceuticals, Inc. 4

4 · VioQuest Pharmaceuticals, Inc. · Filed Jan 23, 2015

Insider Transaction Report

Form 4
Period: 2015-01-16
DACKO MARK D
DirectorCFO and Secretary
Transactions
  • Award

    Stock Options(right to buy)

    2015-01-16+500,000500,000 total
    Exercise: $0.05From: 2015-01-16Exp: 2025-01-16Common Stock (500,000 underlying)
Holdings
  • Common Stock

    0
  • Stock Options (right to buy)

    Exercise: $0.02From: 2013-05-31Exp: 2023-05-31Common Stock (500,000 underlying)
    500,000

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -